Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee
Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee
Not yet recruiting · NCT07550231 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee | Osteoarthritis of the Knees | Not yet recruiting | Phase 2 | 2026-04-24 | NCT07550231 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Addpharma Inc. | 24 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||